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Abstract
Butenolide [5-octylfuran-2(5H)-one] is a recently discovered and very promising anti-marine-fouling compound. In this
study, the acute toxicity of butenolide was assessed in several non-target organisms, including micro algae, crustaceans,
and fish. Results were compared with previously reported results on the effective concentrations used on fouling (target)
organisms. According to OECD’s guideline, the predicted no effect concentration (PNEC) was 0.168 mgl
21, which was
among one of the highest in representative new biocides. Mechanistically, the phenotype of butenolide-treated Danio rerio
(zebrafish) embryos was similar to the phenotype of the pro-caspase-3 over-expression mutant with pericardial edema,
small eyes, small brains, and increased numbers of apoptotic cells in the bodies of zebrafish embryos. Butenolide also
induced apoptosis in HeLa cells, with the activation of c-Jun N-terminal kinases (JNK), Bcl-2 family proteins, and caspases
and proteasomes/lysosomes involved in this process. This is the first detailed toxicity and toxicology study on this
antifouling compound.
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Introduction
Biofouling is one of the most serious problems in the maritime
industry and aquaculture development. In the marine environ-
ment, submerged surfaces are often colonized by marine
organisms that have come to be called biofoulers, which are
marine organisms that attach to submerged surfaces. Biofoulers
increase the weight, drag and surface corrosion of ships, and lead
to huge costs to maintain mariculture systems and seawater
pipelines [1]. Antifouling compounds are used as biocides in
marine paints that are coated on the submerged surfaces to control
the preponderance of biofoulers. It is estimated that without
antifouling measures, the fuel consumption of ships would increase
up to 40% [2]. However, the toxicity of antifouling compounds is a
major concern. Tributyltin was a widely used antifouling
compound, but it was completely banned in 2008 from the
world’s oceans because of concerns over its toxicity [3]. Several
alternative antifouling compounds have replaced tributyltin,
although most of them are still too toxic to be used for the long
term [4]. Better and less toxic antifouling compounds are needed.
A chemically synthesized butenolide, 5-octylfuran-2(5H)-one
(Figure 1), is a very promising antifouling compound that has
been recently designed and patented by our laboratory. This
compound exhibits broad anti-fouling activity against major
fouling species, such as barnacles, bryozoans and the tube-building
polychaetes. Its antifouling activity has been demonstrated in a
field test [5]. The preliminary toxicity study showed that it has
very low toxicity in its target organisms as indicated by the high
pharmaceutical ratios (LC50/EC50), and it has a simple chemical
structure that makes it easy to be synthesized [5]. The toxicity of
this butenolide in other non-target marine organisms has not yet
been assessed in detail. For any new commercial antifouling
compound, the predicted no effect concentration (PNEC) should
be lower than the predicted environmental concentration (PEC)
both inside harbors and in shipping lanes [6]. Besides determining
its PNEC, it is also important to know the mechanism of toxicity of
a compound. However, due to the paucity of molecular reporters,
it is very difficult to study toxicology in marine organisms. We
therefore used other model organisms to study the possible mode
of action of butenolide. Zebrafish is widely used in pharmacology/
toxicology studies, because it is small, optically transparent,
accessible during development ex utero, and permeable to small
molecules. Its embryogenesis is also very well characterized and a
database of developmental defects (www.zfin.org) in zebrafish
(Danio rerio) is available. Developmental defects in zebrafish caused
by small molecules can be linked to a specific genetic pathway
known to cause the same defect [7,8]. On the other hand, cell
cultures are more suitable for in-depth molecular mechanism
studies, since they are simple and easy to control, and also have a
large molecular toolbox available. In this study, the PNEC of
butenolide was assessed using a toxicity study on non-target
organisms and the previously reported toxicity data on fouling
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was investigated both with zebrafish embryos and with the HeLa
cell line.
Materials and Methods
Chemicals
The antifouling compound 5-octylfuran-2(5H)-one (here re-
ferred to as butenolide) was synthesized by Shanghai Medicilon
Inc (Shanghai, China) The chemical structure for this compound
is shown in Figure 1).
Animal/cell culture and toxicity tests
Tables 1 and 2 summarize the methods used in the cell and
animal culturing and toxicity tests, respectively. To identify a
suitable cell line for this toxicology study, the dosage-dependent
cytotoxicity of butenolide was determined in several cell lines with
a MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) assay [9]. From HeLa, SF9 cells or primary neuron cultures,
the supernatant was removed and 20 ml of MTT (2.5 mg ml
21)
were added to each well. After incubation at 37uC for 4 h, 100 ml
of dimethyl sulfoxide (DMSO) were added to each well and
incubated for 20 min. The absorbance of each well was then
measured at 570 nm by a Thermo scientific MultiskanH FC
multiplate photometer (Waltham, MA, USA). The inhibitory
effect or cytotoxicity of butenolide was then calculated based on
the following equation:
Cytoxocity % ðÞ ~(ODno butenolide{ODtreatment)=
(ODno butenolide{ODno cell)|100%
To HL-60 and K562 cells, 20 ml of MTT (2.5 mg ml
21) were
added to each well and incubated for 4 h. They were centrifuged
for 5 min at 1000 rpm and 100 ml of DMSO was added to the
pellet and incubated for 20 min to solubilize the dark-blue
formazan. Absorbance of the solution was measured at 570 nm
and the cytotoxicity was calculated as described above.
Cell cultures of Skeletonema costatum, in the exponential growth
stage were diluted 20 fold in an f/2 culture medium (Table 2). The
cell densities at the onset and completion of the experiment were
measured by counting on a hemocytometer [10].
Calculation of predicted no effect concentration (PNEC)
The predicted no effect concentration (PNEC) was calculated
according to the equation below using the lowest no effect
Figure 1. The chemical structure of butenolide [5-octylfuran-
2(5H)-one].
doi:10.1371/journal.pone.0023803.g001
Table 1. Source and culture methods of organisms used in the toxicity tests.
Toxicity test preparation
Culture
medium Culture condition Source of organism
HeLa cell 1 Seeded at 4000–5000 cells well
21, 24 h in 5% CO2 at 37uC ATCC, Manassas, VA
Ptk2 cell 2 Seeded at 50000 cells well
21, 24 h in 5% CO2 at 37uC ATCC, Manassas, VA
Sf9 cell 3 Seeded at 4000–5000 cells well
21, 24 h at 28uC, 75 rpm shaking ATCC, Manassas, VA
HL-60 cell 4 Seeded at 50000 cells well
21, 24 h in 5% CO2 at 37uC ATCC, Manassas, VA
K562 cell 4 Seeded at 50000 cells well
21, 24 h in 5% CO2 at 37uC ATCC, Manassas, VA
Primary cortical neuron 12 Seeded at 6000 cells well
21, 15 d in 5% CO2 at 37uC. One third of the
medium was replaced by fresh medium every 4 days of culture
Embryonic day 18 (E18) rats [35]
Melita longidactyla 5 Animals of 0.5–1 cm were maintained .24 h at 2261uC Hong Kong coastal waters
Tigriopus japonicus 5 Maintained .48 h under 2261uC, fed with micro algae Isochrysis galbana 24.434335N,118.090925E
Daphnia magna 7 Fed stock daphnids with green alga Chlamydomonas reinhardtii.
Collect young (,24 h) daphnids
Institute of Hydrobiology, Chinese
Academy of Sciences
Lutjanus erythropterus 5 Juvenile fish of 3–4 cm were maintained .24 h at 2261uC Aqua farm in Shen Zhen, China
Danio rerio 10 Cultured at 28uC. Collect freshly fertilized embryos Provided by Dr. Zi-Long Wen
Skeletonema costatum 11 Cultured at 24uC to exponential growth phase
and seeded at 8*10
8 cells ml
21
Hong Kong coastal waters
1—Minimum essential medium (MEM) containing 10% fetal bovine serum (FBS), 100 mg l
21 penicillin and 100 mg l
21 streptomycin.
2—Dulbecco medium supplemented with 10% heat-inactivated fetal calf serum.
3—Sf-900 II SFM.
4—RPMI-1640, supplemented with 10% heat-inactivated fetal calf serum.
5—Fully aerated seawater at salinity: 3361%.
6—Fully aerated 0.22 mm filtered seawater at salinity: 3361%.
7—Glass-fiber (GF/C Whatman, Maidstone, UK) filtered freshwater.
8—ISO testing water (1) [36].
9—Fully aerated 1 mm filtered seawater at salinity: 3361%.
10—60 mgm l
21 instant ocean sea salts dissolved in water.
11—f/2 culture medium [37].
12—Neural basal medium with B27 (Invitrogen, Carlsbad, CA, USA) and 0.5 mM GlutaMAX.
doi:10.1371/journal.pone.0023803.t001
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PNEC~lowest NEC or L E ðÞ C50=AF
Histological analysis and light microscopy
Zebrafish embryos treated with 1.25 mgm l
21 butenolide from the
two-cell stage or the control embryos were fixed at 48 hours post
fertilization (hpf) in 10% formalin in PBS overnight at 4uC. The
samples were dehydrated in ethanol and infiltrated in paraffin resin
(paraplast plus, McCormick Scientific, Richmond, USA) following the
manufacturer’s instructions. The specimens were then sectioned at
7 mm using a Leica Reichert-Jung 820-II Histocut Microtome (Leica
Microsystems, Wetzlar, Germany). Histological hematoxylin-eosin
(HE) staining of the sections was subsequently carried out using
standard protocols [11]. The sections were then examined under an
Olympus BX51 upright microscope connected to a Spot insight QE
digital camera. The whole mount/live zebrafish embryos were
manually dechorionated and examined under a Nikon MULTI-
ZOOM AZ100 fluorescent microscope (NIKON CORPORATION,
Tokyo, Japan) connected to a SPOTH FLEX color camera (SPOT
Imaging Solutions, Diagnostic Instruments, Inc., Sterling Heights, MI,
USA). Images were taken with the SPOTH advanced software (SPOT
Imaging Solutions, Diagnostic Instruments, Inc., Sterling Heights, MI,
USA) and then analyzed with Helicon focus (Helicon Soft Ltd.,
Kharkov, Ukraine) (for whole mount images) and Adobe Photoshop
CS3 (Adobe Systems Incorporated, San Jose, CA, USA).
Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) assay
Zebrafish embryos treated with 1.25 mgm l
21 butenolide from
the two-cell stage or the control embryos were fixed at 24 hpf in
4% paraformaldehyde in PBS for 45 min at room temperature.
Whole-mount TUNEL staining of zebrafish embryos was
performed using a fluorescein in situ cell death detection kit
(Roche Applied Science, Indianapolis, USA) according to the
manufacturer’s protocol. Images were taken under a Nikon
MULTIZOOM AZ100 fluorescent microscope with a GFP-B
filter set (EX 460–500 nm, DM 505 nm, BA 510–560 nm) and a
SPOTH FLEX color camera as described above.
Western blotting
HeLa cells were cultured in 60 mm Petri-dishes. Cells at
different time points after butenolide treatment were collected and
lysed in NP-40 lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM
NaCl, and 1% NP-40) in the presence of protease inhibitors.
Whole cell lysates (60 mg lane
21) were separated on 10% SDS-
PAGE and transferred onto a Hybond ECL nitrocellulose
membrane (Amersham Biosciences, Piscataway, NJ, USA). After
blocking, the membranes were incubated for 3 h at room
temperature or overnight at 4uC with antibodies at a dilution of
1:1000. The membranes were then incubated with horseradish
peroxidase-conjugated secondary antibody at a dilution of 1:5000
for 1 h and developed using Immobilon
TM Western detection
reagents (Millipore, Billerica, MA, USA).Information on the
antibodies used in the experiments is summarized in Table 3.
Apoptosis suppression assay
To test the inhibitors of the apoptosis regulators, HeLa cells
were seeded into a 24-well culture plate. Inhibitors were added 1 h
before the application of 100 mgm l
21 butenolide. The inhibitors
tested were 10 mM ALLN (N-Acetyl-Leu-Leu-Nle-CHO), 10 mM
MG132 (Calbiochem, La Jolla, CA, USA), 50 mM Z-VAD-FMK
(Promega, Madison, WI, USA), and 50 mM SP600125 (LC
Laboratory, Woburn, MA, USA). The cytotoxicity was measured
Table 2. Toxicity test methods.
1
Test solution
Tested butenolide
concentrations (mgm l
21) Toxicity test set up Endpoint
HeLa cell 1 0, 5, 10, 25, 50, 75, 100, 200 96-well plate, 3 replicates 17 h cytotoxicity
Ptk2 cell 2 0, 6.25, 12.5, 25, 50, 75, 150 96-well plate, 3 replicates 12 h cytotoxicity
Sf9 cell 3 0, 5, 10, 25, 50, 75, 100, 200 96-well plate, 3 replicates 24 h cytotoxicity
HL-60 cell 4 0, 12.5, 25, 50, 75 96-well plate, 3 replicates 24 h cytotoxicity
K562 cell 4 0, 12.5, 25, 50, 75 96-well plate, 3 replicates 24 h cytotoxicity
Primary cortical neuron 12 0, 6.5, 12, 25, 50, 100 96-well plate, 3 replicates 48 h cytotoxicity
Melita longidactyla 6 0, 1, 1.75, 2.5, 3.25, 5 10 animals per 100 ml test
solution64 replicates
48 h lethality
Tigriopus japonicus 6 0, 0.5, 1, 1.75, 2.5, 3, 4 10 animals per 25 ml glass beaker
containing 10 ml test solution64
replicates
48 h lethality
Daphnia magna 8 0, 0.032, 0.16, 0.80, 4.0, 20 10 animals per 50 ml Falcon
TM
tube containing 25 ml test
solution64 replicates
48 h immobilisation
Lutjanus erythropterus 9 0, 0.06, 0.14, 0.29, 0.56, 0.70,
1.0, 1.5, 2.0, 2.5
10 fishes per 5 L flask containing
4 L test solution63 replicates
48 h lethality
Danio rerio 10 0, 0.5, 1.0, 1.25, 2.5, 3.0, 3.5,
4.0, 4.5, 5.0
#5 embros well
21 in 24-well
plate (1 ml test solution well
21)
Development of pericardial edema
and lethality at 55pfh (for EC50 and
LC50, respectively)
Skeletonema costatum 11 0, 0.08, 0.4, 2, 10, 50 24-well plate, 1.35610
16 quanta
sec
21 cm
22, 14 h/10 h light/dark
cycle, 4 replicates
5dI C 50
1Please see Table 1 for footnotes.
doi:10.1371/journal.pone.0023803.t002
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effects of over-expression of Bcl-2 family proteins on butenolide-
induced apoptosis, HeLa cells seeded in 35 mm Petri dishes were
transfected with 1 mg of empty vector, Bcl-2, Mcl-1 or Bcl-XL
constructs by lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA)
and incubated in an MEM medium containing 5% FBS at 37uC
for 24 h before the application of 100 mgm l
21 of butenolide. The
Bcl-2, Mcl-1 and Bcl-XL constructs tagged with green fluorescent
protein were generously provided by Professor Donald C. Chang
of HKUST. The cell toxicity was measured after 3 h of butenolide
treatment by counting dead cells and total cell numbers under a
fluorescent microscope.
Results
Butenolide’s acute toxicity
The results of acute toxicity tests of butenolide in several marine
and freshwater non-target organisms belonging to different taxo-
nomic groups are summarized in Table 4. The lowest L(E)C50 was
0.0168 mgm l
21 (Hydroides elegans larvae) [5] among the freshwater or
saltwater representative species of three taxonomic groups of three
trophic levels (phytoplankton: Skeletonema costatum; crustaceans: Balanus
amphitrite larvae, Melita longidactyla, Tigriopus japonicus and Daphnia
magna; and fish: Lutjanus erythropterus and Danio rerio embryos) as well as
two additional marine taxonomic groups (Bugula neritina larvae and
Hydroides elegans larvae) [5]. According to the technical guidance on
riskassessmentfromtheEuropeanChemicalsBureau(http://ecb.jrc.
ec.europa.eu/documents/TECHNICAL_GUIDANCE_DOCU-
MENT/EDITION_2/tgdpart2_2ed.pdf), the AF was set at 1000
in the calculation, resulting in a PNEC of 0.0168 mg l-1.
According to guidelines for the testing of chemicals from the
Organization for Economic Co-operation and Development
(OECD) (http://www.oecd.org/dataoecd/6/14/2483645.pdf), the
assessment factor shall be 100 and thus, the PNEC would be
0.168 mg l-1. The positive controls for these toxicity tests are
provided in Table S1.
The mechanism of butenolide’s acute toxicity on
zebrafish embryos
Zebrafish embryos developed pericardial edema (edema around
the heart), poor blood circulation, small brains and small eyes within
55 hours of treatment with butenolide (from the 2-cell stage). The
severity of these symptoms increased as the concentration of
butenolide increased (Table 5, Figure 2a–d, i–l). For example, with
a butenolide treatment of 0.5 mg ml-1, the number of embryos that
had pericardial edema was only 2 out of 14; but with a treatment of
1.25 mg ml-1, the number increased to 10 out of 12 (Table 5). When
the embryos were treated from 23 hours post fertilization (hpf), the
phenotype was similar but weaker than those treated from the 2-cell
stage (Figure 2e–h). The TUNEL assay results showed an abnormal
increase in apoptotic cells in the embryo fish bodies treated with
butenolide, indicating that butenolide induced apoptosis in zebrafish
embryos (Figure 2m–n). The hatching of butenolide-treated fish was
slightly earlier than in the control, but the dose-response relationship
was not very clear (Table S2, up to 2.5 mg ml-1). It appears that the
butenolide had no effect on the final hatched percentage.
Molecular mechanism of butenolide’s acute toxicity in
HeLa cells
The concentration of butenolide that led to toxicity in HeLa,
Ptk2, Sf9, HL-60 and K562 cells was similar, whereas the primary
neuron cells were more sensitive to butenolide treatment than the
other cell types (Table S3). Because of their ease of manipulation
and the consistency and robustness of their results, HeLa cells were
used for the subsequent toxicology studies (Figure 3a). Similar to its
effect on zebrafish embryos, butenolide also induced apoptosis in
HeLa cells, which was confirmed by counter staining with Hoechst
33342 (data not shown).
As revealed by the Western blot analysis (Figure 3b), the caspase
substrate protein PARP (poly ADP ribose polymerase) showed
cleavage after 2 h of treatment, suggesting the activation of
protease caspase-3 and execution of apoptosis.
In the early stages (within 2 h) of treatment with butenolide,
MAPKs family members JNK (c-Jun N-terminal kinases) and
ERK (extracellular signal-regulated kinases) were activated
(phosphorylated), whereas p38 was activated later (after PARP
cleavage) (Figure 3b). The JNK inhibitor SP600125 partially
inhibited butenolide-induced HeLa cell apoptosis (Figure 3d),
whereas p38 and ERK inhibitors had no significant inhibiting
effect (data not shown), suggesting that JNK is involved in
butenolide-induced apoptosis and is the most important MAPK
family protein involved in this process.
Table 3. Antibodies used in this study.
Antigen Antibody Source
Mcl-1 Rabbit anti-Mcl-1 (S-19) polyclonal antibody Santa CruZ Biotechnology, Inc. (Santa Cruz, CA, USA)
Bax Rabbit anti-Bax polyclonal antibody Cell Signaling Technology, Inc. (Danvers, MA, USA)
PUMA Rabbit anti-PUMA polyclonal antibody Cell Signaling Technology, Inc. (Danvers, MA, USA)
Phospho-JNK Rabbit anti-phospho-SAPK/JNK (Thr183/Tyr185)
polyclonal antibody
Cell Signaling Technology, Inc. (Danvers, MA, USA)
Phospho-p38 Rabbit anti-phospho-p38 MAPK (Thr180/Tyr182)
polyclonal antibody
Cell Signaling Technology, Inc. (Danvers, MA, USA)
Phospho-ERK Rabbit anti-phospho-p44/42 MAPK (Erk1/2)
(Thr202/Tyr204) polyclonal antibody
Cell Signaling Technology, Inc. (Danvers, MA, USA)
PARP Mouse anti-PARP (F-2) monoclonal antibody Santa CruZ Biotechnology, Inc. (Santa Cruz, CA, USA)
GADPH Rabbit GAPDH (14C10) monoclonal Antibody Cell Signaling Technology, Inc. (Danvers, MA, USA)
Cdc2 mouse anti-cdc2 p34 (17) monoclonal antibody Santa CruZ Biotechnology, Inc. (Santa Cruz, CA, USA)
Rabbit IgG Goat anti rabbit IgG-peroxidase antibody Sigma-Aldrich (St. Louis, Missouri, USA)
Mouse IgG anti-mouse IgG, HRP-linked antibody Cell Signaling Technology, Inc. (Danvers, MA, USA)
doi:10.1371/journal.pone.0023803.t003
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change with butenolide treatment (Figure 3b). However, the Bcl-2
family proteins PUMA and Mcl-1 were up-regulated in the early
stages of butenolide treatment (Figure 3b), suggesting that Bcl-2
family proteins are involved in butenolide-induced apoptosis. The
over-expression of the anti-apoptotic Bcl-2 family proteins, Bcl-2,
Bcl-XL and Mcl-1, protected the cells from butenolide-induced
apoptosis (Figure 3c), indicating that butenolide’s pro-apoptotic
effect involves Bcl-2 family proteins.
The pan-caspase inhibitor z-VAD-fmk [12,13] partially inhibited
butenolide-induced apoptosis in the HeLa cells (Figure 3d),
indicating that butenolide-induced apoptosis in HeLa cells requires
caspases. The proteasome, lysosome and calpain inhibitors ALLN
and MG132 [14,15] also partially protected the cells from
butenolide-induced apoptosis (Figure 3d). However, calpain is a
calcium-activated protease[16],andthe selectiveintracellularCa2+
stores chelator BAPTA-AM [17,18] had no significant rescuing
effect (Figure 3d), indicating that calpain might have less effect on
butenolide-induced apoptosis, and that proteasomes and/or
lysosomes are involved in butenolide-induced apoptosis.
Discussion
To assess the toxicity of a new antifouling compound, we
calculated the predicted no effect concentration (PNEC) according
to two standards with different AFs. When calculated and
compared using the OECD’s standard, the PNEC of butenolide
is among the highest in representative alternative new biocides
[4,19].
Regarding the selection of test species, we investigated more
organisms than the minimum requirements, which requires three
species from three trophic levels, and preferably two additional
marine taxonomic groups for PNEC calculations [4,6]. Specifi-
cally, we considered several fouling species in the PNEC
calculation in addition to non-target organisms. Although fouling
organisms are target organisms for antifouling compounds, their
ordinary lives should not be affected by these compounds where
these organisms were harmless; and the effective concentrations on
these species are important references for the prediction of the
effective concentrations in other species. As of now, the fouling
species H. elegans, B. neritina, and B. amphitrite were found to be
among the most sensitive species to butenolide. Species-selectivity
ratios/indices were used to assess the species-selectivity of
herbicides [20,21]. Here, we used a similar method to compare
the species-selectivity of several antifouling compounds (Table 6)
by the following equation:
Species   selectivity ratio based on acute toxicity test ðÞ ~
lowest L E ðÞ C50 in non   target organisms=
highest EC50 in target organisms determined
preferably by settlement assay
This ratio indicates the compound’s species-specificity under the
most extreme conditions, which are most likely to exist in places
near the antifouling coatings. A higher value suggests higher
specificity towards target organisms. The species-selectivity ratio
for butenolide is 0.635, which is quite high compared to other
biocides (Table 6), suggesting that butenolide is comparatively
more specific towards fouling organisms than are other biocides.
This makes butenolide desirable as an antifouling compound.
The species-selectivity ratio of butenolide is much lower than its
pharmaceutical ratios. The pharmaceutical ratios (LC50/EC50)
were based on single species. When used on fouling organisms, the
pharmaceutical ratio assessed the specificity of the compound’s
effect, with a higher value suggesting higher specificity toward the
Table 4. Effects of butenolide on different organisms.
EC10 EC50 LC10 LC50 Endpoint Reference
Non target organisms
Micro algae Skeletonema costatum 0.33 5 d IC50
Crustacean Melita longidactyla 2.22 3.02 48 h lethality
Tigriopus japonicus 1.82 2.56 48 h lethality
Daphnia magna 0.58 2.34 48 h immobilisation
Fish Lutjanus erythropterus 0.77 1.32 48 h lethality
Danio rerio 0.35 0.89 2.75 3.27 Development of pericardial
edema/lethality at 55pfh
Target organisms (fouling organisms)
Crustacean Balanus amphitrite 0.518 .50 48 h settlement [5]
Bryozoan Bugula neritina 0.199 .50 12 h settlement [5]
Annelidian Hydroides elegans 0.0168 .2 48 h settlement [5]
All concentrations are in mgm l
21.
doi:10.1371/journal.pone.0023803.t004
Table 5. Effects of different concentrations of butenolide on
zebrafish embryos treated at the 2-cell stage and observed at
48 hpf (hours post fertilization).
Concentration of
butenolide Number of zebrafish embryos
Total Normal Pericardial edema Died
0 mgm l
21 12 12 0 0
0.50 mgm l
21 14 12 2 0
1.25 mgm l
21 12 2 10 0
2.50 mgm l
21 12 0 12 0
5.0 mgm l
21 12 0 0 12
doi:10.1371/journal.pone.0023803.t005
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tical ratio of butenolide was quite high in target organisms (.97
for B. amphitrite, .250 for B. neritina, .119 for H. elegans) [5], but
much lower in the embryos of the non-target organism D. rerio
(3.67). The exact mechanism for this huge difference is unclear,
but one possibility is that butenolide has a very specific effect on
the fouling process in fouling organisms but much less specific
effects on non-target organisms. The variation in the L(E)C50 of
butenolide in different non-target species is within an order of
magnitude, which is quite low among new antifouling biocides [4],
suggesting that butenolide does not discriminate much among
non-target organisms and is less likely to cause selective loss of a
particular non-target organism in the environment. The L(E)C50
varies by at least an order of magnitude between target organisms;
and LC50 of non-target crustaceans was much lower than that of
the crustacean B. Amphitrite. The pharmacology of butenolide in
different species should be investigated to clarify the reasons for
these inter-species differences.
To guarantee the safe usage of butenolide as antifouling
compound, its degradation should be further studied to ensure
that the effective concentrations are reached only within a very
limited space near the coating. Our preliminary data on
butenolide degradation showed that it can be easily degraded
after its release into natural sea water (unpublished results).
During zebrafish organogenesis, the heart is the first organ
formed in the developing embryo, and the development of other
organs depends on blood circulation in the embryo. Pericardial
edema was the first symptom observed after treatment with
butenolide, and blood circulation in the embryos was in turn
affected. It is possible that the developmental defects/retardation
in the brains and eyes were caused by insufficient blood
circulation. We therefore focused only on pericardial edema and
looked for similar phenotypes. Using the key words ‘‘pericardial
edema’’ to search the zebrafish embryo developmental defect
database, we found that the symptoms caused by butenolide were
similar to the phenotype found in pro-caspase-3 over-expression
mutants [22], which have pericardial edema, small brains, small
eyes and abnormal increases of apoptotic cells in the body. The
similarity indicates that butenolide induces apoptosis in zebrafish
embryos and suggests that butenolide’s phenotype in zebrafish
embryos was the result of apoptosis. Therefore, pro-apoptosis is
likely to be the major effect of butenolide on this organism.
However, there were some differences between the pro-caspase-
3 over-expression mutants and the butenolide-treated embryos. In
the pro-caspase-3 mutants, some retina cells were lost in the eyes,
especially in the photoreceptor cell layer, and the number of
apoptotic cells in the retina increased [22]. However, in the
butenolide-treated embryos, the eyes were well structured; the
retina cells were well organized and densely compacted; and there
was no obvious cell loss or specific sensitivity of the photoreceptor
cell layer to butenolide. Also, we did not observe any increase in
the number of apoptotic cells in the retina in our TUNEL assays of
both whole mount and tissue sections (data not shown). Perhaps
the cause of the small eye phenotype differs between the pro-
caspase-3 over-expression mutants and the butenolide-treated
embryos. The higher activity of caspase-3 in the retina might lead
to retina cell loss and small-eye defects in the pro-caspase-3
overexpression mutants, whereas pericardial edema and poor
blood circulation might be the reasons for the defects/develop-
mental retardation in the eyes of the butenolide-treated embryos.
These results suggest that the mechanism of apoptosis induced by
butenolide involves more than just the overall higher activity of
caspase-3.
To study the molecular mechanism of butenolide-induced
apoptosis, we used a representative cell culture to examine the
mechanism of butenolide’s direct effect. The LC50s in the tested
cell lines were higher than in the non-target organisms. Although
the reason for this discrepancy is unclear, it is important to
understand that the direct effect on cells differs from the most
prominent effects on the whole organism, and that the host
species, cell type and culture method could all influence the
sensitivity of the cell to butenolide. Among several cell types, HeLa
cells were chosen for molecular toxicology study, because they are
very consistent, robust, and easy to manipulate, and butenolide’s
effective concentration in this cell line was similar to that in most of
the other tested cell lines, including the insect cell line Sf9. The
concentration of butenolide for the molecular mechanism study
was 100 mgm l
21. This concentration was just high enough to
cause sufficient cytotoxicity (Figure 3a), while low enough to avoid
necrosis as confirmed by counter staining with Hoechst 33342
(data not shown).
The MAPKs family includes ERK1/2, JNK/SAPK, p38 and
ERK5. These proteins are involved in the survival, proliferation
and differentiation of cells [23]. Bcl-2 family proteins exhibit either
pro- or anti-apoptotic activities and regulate the mitochondrial
pathways of apoptosis by controlling the permeabilization of the
outer mitochondrial membrane [24]. We found that butenolide-
induced apoptosis in HeLa cells involved JNK and Bcl-2 family
proteins. This finding was supported by our inhibitor assays and
over-expression assays, respectively. For instance, the JNK
inhibitors inhibited butenolide-induced apoptosis, whereas the
p38 and ERK inhibitors did not have significant inhibiting effects.
JNK was activated early, suggesting that its regulatory role
may be in the early stages. The Bax protein, which forms
the Mitochondrial Outer Membrane Permeabilization Pore
(MOMPP) and induces apoptosis [25,26], did not change in
expression level (Figure 3b) at the early stage (within 2 h); whereas
PUMA, which initiates apoptosis by dissociating Bax and Bcl-XL,
thereby promoting Bax multimerization and mitochondrial
translocation [27], was activated in the early stages of butenolide
treatment (Figure 3b). This evidence suggests that Bax is activated
early by PUMA upon butenolide treatment. Furthermore, Mcl-1,
Figure 2. The effect of butenolide on zebrafish embryos. a–d) 55 hpf zebrafish embryos treated with different concentrations of butenolide at
the 2-cell stage: a) the control; b) 0.5 mgm l
21 butenolide; c) 1.25 mgm l
21 butenolide; d) 2.5 mgm l
21 butenolide, showing that the treated embryo
had smaller eyes (arrow) than the control and pericardial edema (arrowhead). e–h) Zebrafish embryos treated with different concentrations of
butenolide at 23 hpf and observed at 55 hpf: e) the control, f) 0.5 mgm l
21 butenolide, g) 1.25 mgm l
21 butenolide, h) 2.5 mgm l
21 butenolide. i–j)
High magnification of the pericardial region of zebrafish embryos: i) the control; j) embryo treated with butenolide at 1.25 mgm l
21, revealing an
enlarged space in the pericardial region (arrowhead) and blood congestion (arrow). k–l) HE staining of the transverse sections through optic nerves of
zebrafish embryos 48 hpf (treated at the 2-cell stage): k) control; l) embryo treated with 1.25 mgm l
21 butenolide, note that the butenolide-treated
zebrafish embryo had a smaller brain (see arrowhead) than the control. le, lens; ipl, inner plexiform layer; inl, inner nuclear layer; pcl, photoreceptor
cell layer; pe, pigmented epithelium; bar is 50 mm. m–n) Whole mount TUNEL assay on m) 24 hpf control embryo; n) 24 hpf embryo treated with
1.25 mgm l
21 butenolide from the 2 cell stage, revealing the signal on the embryo fish body (arrowhead).
doi:10.1371/journal.pone.0023803.g002
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according to the logistic regression (R
2=0.897). b) Effect of butenolide on several apoptosis-related proteins in HeLa cells. GADPH and cdc-2 served
as the internal loading controls. c) Over-expression of Bcl-2 family members protected-HeLa cells from butenolide-induced apoptosis at different
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decreased in expression level after 1.5 h (Figure 3b), which is later
than PUMA’s response, and earlier than the cleavage of PARP,
suggesting that Mcl-1 is also involved in the early regulation of
butenolide-induced apoptosis. The over-expression of Bcl-2 family
members that inhibit MOMPP formation (Bcl-2, Bcl-XL or Mcl-1)
[25,28] protected cells from butenolide-induced apoptosis
(Figure 3c), indicating that Bcl-2 family members mediate
butenolide-induced apoptosis.
Proteases are executioners of apoptosis. After apoptosis begins,
cellular organelles undergo organized degradation by activated
proteases [29,30]. Proteases also play a regulatory role in
apoptosis. For example, proteases in proteasome regulate the
degradation of some endogenous Inhibitors of Apoptosis (IAP)
[31]. If the proteasome activity is inhibited, the degradation of
some IAP would be subsequently inhibited, leaving more IAP
available to inhibit apoptosis. In this study, both pan-caspase
inhibitor and proteasome/lysosome inhibitors partially protected
HeLa cells from butenolide-induced apoptosis (Figure 3d), indi-
cating the necessity of these proteases in butenolide-induced
apoptosis. Whether caspase and proteasome/lysosome were
involved before the execution of butenolide-induced apoptosis
remains unclear.
Besides apoptosis, we also tested the effect of butenolide on
several other cell signaling pathways. Butenolide treatment did not
change the proportion of interphase cells (up to 50 mgl
21), which
was verified by FACS analysis (data not shown); 10 mM purvalanol
A (a CDK1 inhibitor) did not inhibit butenolide-induced apoptosis
(data not shown), suggesting that butenolide may have less effect
on the cell cycle.
In the cyprid larvae of the marine fouling organism Balanus
amphitrite, caspase-3 activity decreases 24 h after molting, but it is
partially sustained by butenolide treatment [32]. However, butenolide
can inhibit the positive phototactic behavior of B. amphitrite cyprids
within a few minutes after treatment [33], which is unlikely to be due
to a pro-apoptotic effect, suggesting that butenolide has other effects
on B. amphitrite than only pro-apoptotic activity. The relationship
between the pro-apoptotic effect and the antifouling effect of
butenolide remains unknown. Another type of butenolide [2-(6-
hydroxy-6-methyl-octyl)-2H-furan-5-one], which is structurally similar
to the butenolide studied here, exhibited novel anti-parasitic activities
specifically against Trypanosoma brucei brucei [34]. It is possible that anti-
parasitic butenolide also has pro-apoptotic effects.
In summary, the antifouling compound butenolide’s PNEC was
0.016 mgl
21 according to the European Chemicals Bureau, and
0.16 mgl
21 according to the Organization for Economic Co-
operation and Development (OECD). As of now, the fouling species
Hydroides eleganswasfound to be the most sensitive species to butenolide
treatment and it could be chosen for chronic toxicity tests.
Mechanistically, butenolide induced apoptosis in both zebrafish
embryos and HeLa cells. JNK activation, Bcl-2 family members,
caspases and proteasome/lysosome activation were involved in
butenolide-induced apoptosis in HeLa cell lines. The results reported
here increased our understanding on butenolide’s toxicity and
degrees. Note that the PARP is cleaved after 2 h of butenolide treatment. d) Effect of inhibitors on butenolide-treated HeLa cells (see text). JNK-I: JNK
inhibitors. ** indicates significant difference between the treatment and the control (100 mgm l
21 butenolide) at p,0.01. NS indicates no significant
difference between the treatment and the control. Error bars represent standard deviations.
doi:10.1371/journal.pone.0023803.g003
Table 6. Species-selectivity ratio of biocides
1.
Biocide Species
Highest
EC50 in
target
organism
Lowest
L(E)C50 in
non-target
organism Endpoint
Species-selectivity
ratio Reference
Butenolide Balanus amphitrite (cyprid) 0.518 48 h settlement rate 0.64 [5]
Skeletonema costatum 0.33 5 d I(E)C50 This work
Chlorothalonil Hydroides elegans (trochophore) 0.012 48 h LC50 0.37 [38]
Thalassiosira pseudonana 0.0044 96 h EC50 [38]
TBT Balanus amphitrite (cyprid) 0.034 24 h LC50 0.032 [38]
Skeletonema costatum 0.0011 96 h EC50 [38]
CuPT Balanus amphitrite (cyprid) 0.063 24 h LC50 0.011 [38]
Thalassiosira pseudonana 0.0007 96 h EC50 [38]
ZnPT Balanus amphitrite (larvae) 0.21 24 h LC50 0.0024 [38]
Thalassiosira pseudonana 0.0005 96 h EC50 [38]
Seanine 211 Bugula neritina (swimming larvae) 2.5 48 h settlement EC50 0.00108 Unpublished data
Oncorhynchus mykiss 0.0027 72 h IC50 [4]
Diuron Balanus amphitrite (larvae) 21 24 h LC50 0.0002 [38]
Thalassiosira pseudonana 0.0043 96 h EC50 [38]
Irgarol Hydroides elegans (trochophore) 2.6 48 h LC50 0.00015 [38]
Thalassiosira pseudonana 0.0004 96 h EC50 [38]
All concentrations are in mgm l
21.
1The species-selectivity ratios for antifouling compounds other than butenolide are tentative estimations from limited sources.
doi:10.1371/journal.pone.0023803.t006
Butenolide’s Toxicity and Toxicology
PLoS ONE | www.plosone.org 9 August 2011 | Volume 6 | Issue 8 | e23803toxicology. For risk assessment, the degradation, bioaccumulation,
and the predicted environment concentration (PEC) of butenolide
should be further measured and calculated [6] in the future.
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